Steven J. Buhaly - Feb 16, 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Financial Officer
Signature
/s/ Steven J. Buhaly
Stock symbol
BSGM
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
4
Date filed
2/17/2023, 02:03 PM
Previous filing
Feb 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Stock Option (Right to Buy) Award $0 +250K $0.00 250K Feb 16, 2023 Common Stock 250K $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.